Citation Impact
Citing Papers
Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes
2015 Standout
Melatonin modulated autophagy and Nrf2 signaling pathways in mice with colitis‐associated colon carcinogenesis
2015
Treatment failure in hepatitis C: Mechanisms of non-response
2008
Validation of TaqMan® SNP genotyping specificity for rs12979860 of IL-28B: Modeling primer specificity in vitro
2014
Treatment predictors of a sustained virologic response in hepatitis B and C
2008
Inflammation and metabolic disorders
2006 StandoutNature
Association of pretreatment serum interferon γ inducible protein 10 levels with sustained virological response to peginterferon plus ribavirin therapy in genotype 1 infected patients with chronic hepatitis C
2005
Industrial, not fruit fructose intake is associated with the severity of liver fibrosis in genotype 1 chronic hepatitis C patients
2013
Recapitulation of the hepatitis C virus life-cycle in engineered murine cell lines
2013 StandoutNobel
Impact of obesity on treatment of chronic hepatitis C†
2006
The Evolving Role of Leptin and Adiponectin in Chronic Liver Diseases
2006
Longitudinal transcriptomic characterization of the immune response to acute hepatitis C virus infection in patients with spontaneous viral clearance
2018 StandoutNobel
Treatment triumphs
2014 StandoutNatureNobel
Steatosis and insulin resistance in response to treatment of chronic hepatitis C
2012
Hepatic steatosis and insulin resistance are associated with severe fibrosis in patients with chronic hepatitis caused by HBV or HCV infection
2011
Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
2015 Standout
Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease
2010
Delayed Induction, Not Impaired Recruitment, of Specific CD8+ T Cells Causes the Late Onset of Acute Hepatitis C
2011 StandoutNobel
Emerging Therapeutic Targets for Hepatitis C Virus Infection
2013
Hepatitis C: viral and host factors associated with non-response to pegylated interferon plus ribavirin
2010
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Hepatitis C infection and risk of diabetes: A systematic review and meta-analysis
2008
Virus associated malignancies: The role of viral hepatitis in hepatocellular carcinoma
2014 StandoutNobel
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
2016 Standout
Insulin Resistance in Chronic Hepatitis C: Association With Genotypes 1 and 4, Serum HCV RNA Level, and Liver Fibrosis
2007
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
2021 Standout
Peginterferon Alfa-2a and Ribavirin in Latino and Non-Latino Whites with Hepatitis C
2009
Antioxidant therapy for treatment of inflammatory bowel disease: Does it work?
2015 Standout
Mechanisms of Hepatic Fibrogenesis
2008 Standout
Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
2012 Standout
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
2014 Standout
Post‐Transplant Diabetes Mellitus and HCV Seropositive Status After Renal Transplantation: Meta‐Analysis of Clinical Studies
2005
Enhanced Activation of Memory, but Not Naïve, B Cells in Chronic Hepatitis C Virus-Infected Patients with Cryoglobulinemia and Advanced Liver Fibrosis
2013 StandoutNobel
Hepatitis C virus: How genetic variability affects pathobiology of disease
2011
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
2009 StandoutNature
Genetics of IL28B and HCV—response to infection and treatment
2012
Genes and hepatitis C: susceptibility, fibrosis progression and response to treatment
2011
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
2010 Standout
Obesity and infection
2006
Protease and polymerase inhibitors for the treatment of hepatitis C
2009
Phase 2b Trial of Interferon-free Therapy for Hepatitis C Virus Genotype 1
2014
The global NAFLD epidemic
2013 Standout
The quasispecies nature and biological implications of the hepatitis C virus
2009
The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology
2012
Mechanisms and significance of liver steatosis in hepatitis C virus infection
2006
IL-28B is a Key Regulator of B- and T-Cell Vaccine Responses against Influenza
2014 StandoutNobel
Impact of hepatic steatosis on viral kinetics and treatment outcome during antiviral treatment of chronic HCV infection
2006
Extrahepatic Morbidity and Mortality of Chronic Hepatitis C
2015
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
2012 Standout
The Natural History of Hepatitis C Virus (HCV) Infection
2006
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
2015 Standout
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
2014 Standout
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
2013 StandoutNobel
Impact of obesity, steatosis and insulin resistance on progression and response to therapy of hepatitis C
2009
Prediction of Response to Pegylated Interferon and Ribavirin in Hepatitis C by Polymorphisms in the Viral Core Protein and Very Early Dynamics of Viremia
2007
Boceprevir for Untreated Chronic HCV Genotype 1 Infection
2011 Standout
Replication of hepatitis C virus
2007 StandoutNobel
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Prolonged activation of innate antiviral gene signature after childbirth is determined byIFNL3genotype
2016
Genetic Variation at IFNL4 Influences Extrahepatic Interferon-Stimulated Gene Expression in Chronic HCV Patients
2017 StandoutNobel
Polymorphisms in melanoma differentiation‐associated gene 5 link protein function to clearance of hepatitis C virus
2014 StandoutNobel
Tirzepatide Once Weekly for the Treatment of Obesity
2022 Standout
Internal Initiation Stimulates Production of p8 Minicore, a Member of a Newly Discovered Family of Hepatitis C Virus Core Protein Isoforms
2009 StandoutNobel
The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation
2009 Standout
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Meta‐analysis: insulin resistance and sustained virological response in hepatitis C
2011
The HCV IRES pseudoknot positions the initiation codon on the 40S ribosomal subunit
2010 StandoutNobel
Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta‐analysis
2017 Standout
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2018 Standout
Broadly neutralizing antibodies abrogate established hepatitis C virus infection
2014 StandoutNobel
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV
2010
American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines For Medical Care of Patients with Obesity
2016
Once-Weekly Semaglutide in Adults with Overweight or Obesity
2021 Standout
Studying Hepatitis C Virus: Making the Best of a Bad Virus
2007 StandoutNobel
Antisense Gets a Grip on miR-122 in Chimpanzees
2010 StandoutNobel
Response of Hepatitis C Virus to Long-Term Passage in the Presence of Alpha Interferon: Multiple Mutations and a Common Phenotype
2013 StandoutNobel
EASL Recommendations on Treatment of Hepatitis C 2018
2018 Standout
Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review.
2011 StandoutNobel
Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
2017 Standout
Analysis of Interferon Signaling by Infectious Hepatitis C Virus Clones with Substitutions of Core Amino Acids 70 and 91
2011
Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years
2017 Standout
Nonalcoholic Fatty Liver Disease
2015 Standout
Obesity-Associated Liver Disease
2008
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Works of A. Gila being referenced
Quasispecies as predictive factor of rapid, early and sustained virological responses in chronic hepatitis C, genotype 1, treated with peginterferon–ribavirin
2008
Hepatic Expression of Adiponectin Receptors Increases with Non-alcoholic Fatty Liver Disease Progression in Morbid Obesity in Correlation with Glutathione Peroxidase 1
2011
Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients
2005
Importance of Host Genetic Factors HLA and IL28B as Predictors of Response to Pegylated Interferon and Ribavirin
2011
Variation of Transaminases, HCV-RNA Levels and Th1/Th2 Cytokine Production during the Post-Partum Period in Pregnant Women with Chronic Hepatitis C
2013
Melatonin reduces endothelin‐1 expression and secretion in colon cancer cells through the inactivation of FoxO‐1 and NF ‐κβ
2014
Mutations in E2-PePHD, NS5A-PKRBD, NS5A-ISDR, and NS5A-V3 of Hepatitis C Virus Genotype 1 and Their Relationships to Pegylated Interferon-Ribavirin Treatment Responses
2008